Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats

被引:37
|
作者
He, XX
Li, CM
Simonaro, CM
Wan, Q
Haskins, ME
Desnick, RJ
Schuchman, EH
机构
[1] CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Inst Gene Therapy & Mol Med, New York, NY 10029 USA
[3] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
关键词
lysosomal storage diseases; animal models; mucopolysaccharidoses;
D O I
10.1006/mgme.1999.2860
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mucopolysaccharidosis Type I (MPS I) is the lysosomal storage disease caused by the deficient activity of alpha-L-iduronidase (IDUA). In man, MPS I can occur in severe, mild, or intermediate forms known as the Hurler, Scheie, or Hurler/Scheie syndromes, respectively. RIPS I also has been described in cats, dogs, and mice. This manuscript reports the identification and characterization of the mutation causing RIPS I in cats. To obtain wild-type feline IDUA cDNAs, two PCR-based strategies were used. PCR primers were constructed from a conserved region of the published human and dog sequences and used to amplify a 224-bp IDUA fragment from normal cat genomic DNA. This fragment was then used to screen a feline uterus cDNA library. PCR also was used to directly amplify IDUA fragments from the same cDNA library. Two overlapping feline IDUA cDNAs encoding 466 amino acid residues of the feline IDUA polypeptide (similar to 85% of the mature protein based on comparison to the human, dog, and mouse sequences) were obtained by these strategies. To identify the mutation causing NIPS I in cats, DNA sequencing was carried out on the corresponding IDUA region from several affected animals. A 3-bp deletion was found on both IDUA alleles in each of the MPS I animals, predicting the deletion of a single aspartate residue from the feline IDUA polypeptide. To confirm the authenticity of this mutation, heteroduplex, SSCP, and transient expression studies were carried out. Over 100 animals from the RIPS I colony were screened for the presence of the mutation by heteroduplex and SSCP analyses-in all cases the presence of the 3-bp deletion was 100% concordant with the disease phenotype. For transient expression studies, the two partial, overlapping feline cDNAs were combined and joined in-frame to the 5' end of the canine IDUA cDNA. This wild-type, hybrid cDNA expressed IDUA activity up to sixfold over endogenous levels after transfection into COS-1 cells. A modified full-length IDUA cDNA containing the 3-bp deletion did not express IDUA activity in a transient expression system, providing proof that this lesion was the cause of feline MPS I. (C) 1999 Academic Press.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 50 条
  • [21] Mucopolysaccharidosis type I and craniosynostosis
    Ziyadeh, Jawad
    Le Merrer, Martine
    Robert, Matthieu
    Arnaud, Eric
    Valayannopoulos, Vassili
    Di Rocco, Federico
    ACTA NEUROCHIRURGICA, 2013, 155 (10) : 1973 - 1976
  • [22] Mucopolysaccharidosis type I and craniosynostosis
    Jawad Ziyadeh
    Martine Le Merrer
    Matthieu Robert
    Eric Arnaud
    Vassili Valayannopoulos
    Federico Di Rocco
    Acta Neurochirurgica, 2013, 155 : 1973 - 1976
  • [23] Mucopolysaccharidosis type I with craniosynostosis
    Sadashiva, Nishanth
    Bindu, Parayil Sankaran
    Santosh, Vani
    Devi, Bhagavatula Indira
    Shukla, Dhaval
    NEUROLOGY INDIA, 2015, 63 (04) : 612 - U226
  • [24] Mucopolysaccharidosis Type I in a Dog
    Amaral, Andreza Da Silva
    Agassi De Sales, Nathali Adrielli
    Rosado, Isabel Rodrigues
    Giugliani, Roberto
    Burin, Maira Graeff
    Baldo, Guilherme
    Martin, Ian
    Leonel Alves, Endrigo Gabellini
    ACTA SCIENTIAE VETERINARIAE, 2021, 49
  • [25] Mucopolysaccharidosis type I in Taiwan
    Lin, SP
    Lee-Chen, GJ
    Chuang, CK
    Hwu, WL
    Kuo, MT
    Yang, C
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 209 - 209
  • [26] Mucopolysaccharidosis type I therapy
    Murillo-Lopez, FH
    ANNALS OF OPHTHALMOLOGY, 2005, 37 (04) : 235 - 236
  • [27] Analysis of cDNA Molecules is Not Suitable for the Molecular Diagnosis of Mucopolysaccharidosis Type I
    Grandini Almeida, Andresa Cardoso
    Pasqualim, Gabriela
    Mayer, Fabiana Q.
    Doderlein Schwartz, Ida Vanessa
    Souza, Carolina F.
    Giugliani, Roberto
    Matte, Ursula
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2012, 21 (01) : 53 - 55
  • [28] Mutation analysis and clinical characterization of Iranian patients with mucopolysaccharidosis type I
    Taghikhani, Mohammad
    Khatami, Shohreh
    Abdi, Mohammad
    Hakhamaneshi, Mohammad Said
    Alaei, Mohammad Reza
    Zamanfar, Daniel
    Vakili, Rahim
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (08)
  • [29] Prevalence of mucopolysaccharidosis type VI mutations in Siamese cats
    Crawley, AC
    Muntz, FH
    Haskins, ME
    Jones, BR
    Hopwood, JJ
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2003, 17 (04) : 495 - 498
  • [30] Molecular characterization of mucopolysaccharidosis type IVA patients in the Andean region of Colombia
    Pachajoa, Harry
    Acosta, Maria Amparo
    Almeciga-Diaz, Carlos J.
    Ariza, Yoseth
    Diaz-Ordonez, Lorena
    Caicedo-Herrera, Gabriela
    Cuartas, Daniel
    Nastasi-Catanese, Jose Antonio
    Ramirez-Montano, Diana
    Silva, Yiseth Katherine
    Moreno, Lina
    Satizabal, Jose
    Garcia, Natalia
    Montoya, Jorge
    Prada, Carlos
    Porras, Gloria
    Velasco, Harvy
    Candelo, Estephania
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2021, 187 (03) : 388 - 395